[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366039-105":59,"doc-detail-366039-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-a-lncrna-based-cerna-network-signature-to-establish-a-prognostic-model-and-explore-potential-therapeutic-targets-in-gastric-cancer","Identification of a LncRNA based CeRNA network signature to establish a prognostic model and explore potential therapeutic targets in gastric cancer","","Long non-coding RNA (lncRNA) can regulate physiological processes and contribute to disease, but prognostic guidance and therapeutic insight for gastric cancer remain limited. This study develops lncRNA-based signatures to predict prognosis in gastric cancer patients and to identify potential therapeutic targets. Gene expression and clinical data were analyzed from TCGA using WGCNA and ceRNA network construction, followed by Cox and Lasso regression to build a five-lncRNA risk model.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-a-lncrna-based-cerna-network-signature-to-establish-a-prognostic-model-and-explore-potential-therapeutic-targets-in-gastric-cancer/366039/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-a-lncrna-based-cerna-network-signature-to-establish-a-prognostic-model-and-explore-potential-therapeutic-targets-in-gastric-cancer/366039.png","ImageObject",300,407,{"name":92,"@type":93},"Bintang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this study on gastric cancer?","Question",{"text":112,"@type":113},"To develop lncRNA-based signatures that predict prognostic risk in gastric cancer patients and provide therapeutic guidance by exploring ceRNA-related mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data and analytical methods were used to build the model?",{"text":117,"@type":113},"TCGA gene expression profiles and clinical information were analyzed with WGCNA and a competing endogenous RNA (ceRNA) network, then Cox regression and Lasso regression were used to construct the risk model.",{"name":119,"@type":110,"acceptedAnswer":120},"How did AP000695.2 relate to prognosis and tumor behavior?",{"text":121,"@type":113},"AP000695.2 expression was associated with poor prognosis and higher T stage, and its knockdown inhibited gastric cancer cell growth both in vitro and in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366039,1790872854,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of a LncRNA based CeRNA network signature to establish a prognostic model and explore potential therapeutic targets in gastric cancer  \nYuanqing An1,5, Xiaomeng Liu1,5, Jin Liu1,5, Deqiang Wang2, Wenying Yan3, Guang Hu3􀀍, LuXu4􀀍 & Wei Li1􀀍  \nNumerous studies have demonstrated that long non-coding RNA (lncRNA) play critical roles in regulating physiological processes and contributing to pathological diseases. This study aimed to develop lncRNA-based signatures to predict the prognostic risk of gastric cancer (GC) patients and provide therapeutic guidance. Gene expression profiles and clinical information were obtained from The Cancer Genome Atlas (TCGA) database. Differentially expressed RNAs, including lncRNA, miRNA, and mRNA, in cancerous and adjacent non-cancerous tissues were analyzed using Weighted correlation network analysis (WGCNA) and construction of a lncRNA-miRNA-mRNA competing endogenous RNA (ceRNA) network. Then, a lncRNA-based risk model was constructed by Cox regression and Lasso regression analyses. A ceRNA network comprising 235 lncRNAs, 60 miRNAs, and 52 mRNAs was identified. Based on the expression of five lncRNAs (including AC010333.1, LINC01579, AP000695.2, LINC00922 and AL121772.1) screened from the ceRNA network, a lncRNA-based risk model was developed, which effectively predict the prognosis of GC patients. The expression of AP000695.2 was significantly associated with poor prognosis and higher T stage. The knockdown of AP000695.2 inhibited the growth of GC cells both in vitro and in vivo. Transfection with miR-144-3p and miR-7-  \n5p mimics attenuate the up-regulation of targets genes, including CDH11, COL5A2, COL12A1, and VCAN, which was induced by AP000695.2, suggesting a ceRNA mechanism. Additionally, elevated VCAN expression was correlated with poorer survival and a reduced response to anti-PD-1 immune checkpoint inhibitor treatment of GC. This study established a lncRNA-based risk model for predicting the prognosis of GC patients and identified a ceRNA mechanism involving AP000695.2-miR-144-3pVCAN, presenting novel biomarkers and therapeutic targets for GC treatment.  \nKeywords Gastric cancer, LncRNA, WGCNA, Prognostic model, Tumor microenvironment, Immunotherapy  \nGastric cancer (GC) ranks among the most prevalent malignant tumors globally and is the fourth leading cause of cancer-related mortality1. The primary treatment for early GC is endoscopic resection, while non-early operable gastric cancer is treated with surgery combination with chemoradiotherapy. Nevertheless, the 5-year survival rate for patients with stage III GC undergoing surgery is only 18–50%2. For those patients with advanced gastric cancer (AGC), chemotherapy and targeted therapy are the main treatment modalities. Unfortunately, some patients do not respond to chemotherapy or quickly develop chemoresistance, resulting in the 5-year survival rate of less than 30%3. Therefore, there is a critical need for novel, validated biomarkers to improve prognosis assessing and guide treatment strategies.  \n1Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. 2Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China. 3Center for Systems Biology, Department of Bioinformatics, School of Biology and Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou 215123, China. 4Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou 215006, China. 5Yuanqing An, Xiaomeng Liu and Jin Liu have contributed equally to this work.  \n􀀍 email: [huguang@suda.edu.cn](huguang@suda.edu.cn); [luxu@suda.edu.cn](luxu@suda.edu.cn); [liwei10@suda.edu.cn](liwei10@suda.edu.cn); dr_[weili@163.com](weili@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nNon-coding RNAs (ncRNAs) are a class of RNA molecules that do","cbCaibC8x5kDb8bw","https://ap.wps.com/l/cbCaibC8x5kDb8bw","pdf",10660844,15,"English","# Materials and methods\n## Data source and processing","[{\"question\":\"What was the main goal of this study on gastric cancer?\",\"answer\":\"To develop lncRNA-based signatures that predict prognostic risk in gastric cancer patients and provide therapeutic guidance by exploring ceRNA-related mechanisms.\"},{\"question\":\"Which data and analytical methods were used to build the model?\",\"answer\":\"TCGA gene expression profiles and clinical information were analyzed with WGCNA and a competing endogenous RNA (ceRNA) network, then Cox regression and Lasso regression were used to construct the risk model.\"},{\"question\":\"How did AP000695.2 relate to prognosis and tumor behavior?\",\"answer\":\"AP000695.2 expression was associated with poor prognosis and higher T stage, and its knockdown inhibited gastric cancer cell growth both in vitro and in vivo.\"}]","Identification of a LncRNA based CeRNA network signature to establish a prognostic model and explore potential therapeutic targets in gastric cancer | PDF",1790163663,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8e718702cfd880b192f802e2de000a3.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e689ee93efd296a5836017d7abeee522.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3d330b469292d3591fe2b78553fb145.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dae1c94bd07ae1c56dcb75f65cc1681.webp",980,1287]